Skip to content
healthcare.dev

PERTZYE

NDC 59767-004, pancrelipase, capsule, delayed release, from Digestive Care, Inc..

Product NDC
59767-004
Status
Listed
Labeler
Digestive Care, Inc.
Dosage form
CAPSULE, DELAYED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA022175
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59767-004 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PANCRELIPASE LIPASE4000 [USP'U]/1
  • PANCRELIPASE AMYLASE15125 [USP'U]/1
  • PANCRELIPASE PROTEASE14375 [USP'U]/1
Package NDCNDC-11Package
59767-004-0159767000401100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (59767-004-01)
59767-004-9959767000499100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (59767-004-99)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/481eec00-9abf-11dd-b71c-0002a5d5c51b

Use it

Look up 59767-004 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59767-004 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59767-004. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.